Status:

COMPLETED

Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery

Lead Sponsor:

Indiana University

Conditions:

Rotator Cuff Tear

Pain, Postoperative

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This document is a protocol for a human research study. This study is to be conducted according to United States standards of Good Clinical Practice in accordance with applicable Federal regulations a...

Detailed Description

Outpatient surgery has become the gold standard for arthroscopic rotator cuff repair. Innovations in pain management with regional anesthesia and multimodal techniques have greatly contributed to this...

Eligibility Criteria

Inclusion

  • Age 18 and older
  • Primary diagnosis of rotator cuff tear
  • Able to provide informed consent
  • Is willing and able to accept text messages

Exclusion

  • Known allergies to the study medications.
  • Known narcotic or alcohol abuse (\< 3 months)
  • Revision rotator cuff surgery
  • Contraindication to regional anesthesia
  • Current narcotic regimen or contract with pain management specialist
  • Diagnosed with any of the following co-morbidities:
  • Pre-existing coagulation disorder

Key Trial Info

Start Date :

October 24 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 22 2020

Estimated Enrollment :

78 Patients enrolled

Trial Details

Trial ID

NCT03822182

Start Date

October 24 2018

End Date

January 22 2020

Last Update

November 12 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

American Health Network

Avon, Indiana, United States, 46123

Single Shot Liposomal Bupivicaine in Rotator Cuff Surgery | DecenTrialz